HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc J Weigensberg Selected Research

Overweight

1/2023Rapid Decline in β-Cell Function and Increasing Adiposity Are Associated With Conversion to Type 2 Diabetes in At-Risk Latino Youth.
4/2015Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents.
1/2015Changes in Bone Biomarkers, BMC, and Insulin Resistance Following a 10-Week Whole Body Vibration Exercise Program in Overweight Latino Boys.
11/2014Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth.
5/2014Meal skipping linked to increased visceral adipose tissue and triglycerides in overweight minority youth.
9/2013Blunted nocturnal cortisol rise is associated with higher carotid artery intima-media thickness (CIMT) in overweight African American and Latino youth.
5/2012Hemoglobin A1c above threshold level is associated with decreased β-cell function in overweight Latino youth.
3/2012CRP is related to higher leptin levels in minority peripubertal females regardless of adiposity levels.
6/2011Subclinical atherosclerosis in Latino youth: progression of carotid intima-media thickness and its relationship to cardiometabolic risk factors.
3/2011Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc J Weigensberg Research Topics

Disease

34Insulin Resistance
01/2017 - 07/2003
33Overweight
01/2023 - 07/2003
17Type 2 Diabetes Mellitus (MODY)
02/2023 - 07/2003
9Obesity
01/2023 - 06/2009
6Prediabetic State (Prediabetes)
12/2015 - 05/2007
6Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2012 - 01/2004
4Glucose Intolerance
05/2007 - 01/2004
3Metabolic Diseases (Metabolic Disease)
01/2014 - 10/2010
3Abdominal Obesity
05/2007 - 01/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2021 - 02/2017
2Hypoglycemia (Reactive Hypoglycemia)
02/2017 - 08/2015
2Atherosclerosis
09/2013 - 06/2011
2Cardiovascular Diseases (Cardiovascular Disease)
09/2013 - 03/2012
2Inflammation (Inflammations)
03/2012 - 02/2011
2Hypertension (High Blood Pressure)
06/2005 - 01/2004
1Hyperinsulinism (Hyperinsulinemia)
08/2010
1Hypoadiponectinemia
05/2007
1Dyslipidemias (Dyslipidemia)
05/2007
1Body Weight (Weight, Body)
01/2007
1Hypertriglyceridemia
01/2004

Drug/Important Bio-Agent (IBA)

37Glucose (Dextrose)FDA LinkGeneric
01/2023 - 07/2003
26Insulin (Novolin)FDA Link
01/2015 - 07/2003
6Hydrocortisone (Cortisol)FDA LinkGeneric
01/2018 - 04/2008
4Biomarkers (Surrogate Marker)IBA
12/2015 - 05/2007
4Triglycerides (Triacylglycerol)IBA
05/2014 - 01/2004
4Dietary Carbohydrates (Carbohydrate, Dietary)IBA
12/2010 - 01/2007
4SugarsIBA
12/2010 - 11/2005
3Hemoglobins (Hemoglobin)IBA
02/2023 - 05/2012
3CarbohydratesIBA
10/2010 - 06/2007
3HDL CholesterolIBA
05/2007 - 01/2004
2Blood Glucose (Blood Sugar)IBA
02/2023 - 05/2021
2Nonesterified Fatty Acids (NEFA)IBA
04/2015 - 02/2011
2C-Reactive ProteinIBA
09/2013 - 03/2012
2LeptinIBA
03/2012 - 06/2009
2LipidsIBA
12/2010 - 04/2008
1Particulate MatterIBA
01/2017
1antiarrhythmic peptide (AAP)IBA
01/2017
1Nitrogen DioxideIBA
01/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2015
1CytokinesIBA
07/2015
1AdipokinesIBA
07/2015
1OsteocalcinIBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
09/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013
1LDL CholesterolIBA
06/2011
1GlucocorticoidsIBA
10/2010
1Hormones (Hormone)IBA
06/2009
1Insulin-Like Growth Factor Binding ProteinsIBA
09/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2008
1Dietary SugarsIBA
11/2007
1AdiponectinIBA
05/2007
1Dietary Fats (Dietary Fat)IBA
09/2005
1HDL LipoproteinsIBA
01/2004

Therapy/Procedure

6Psychotherapy Imagery (Guided Imagery)
01/2022 - 03/2009
4Resistance Training
10/2010 - 07/2006
2Glycemic Control
02/2023 - 08/2015
1Transition to Adult Care
02/2017